Hans H Maurer

发表

Development and validation of a fast and simple multi-analyte procedure for quantification of 40 drugs relevant to emergency toxicology using GC-MS and one-point calibration.

Golo M J Meyer, Armin A Weber, Hans H Maurer, 2013, Drug testing and analysis.

Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine.

Frank T Peters, Markus R Meyer, Hans H Maurer, 2010, Clinical chemistry.

Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control

Hans H Maurer, H. Maurer, 2004, Clinical chemistry and laboratory medicine.

Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry

Frank T Peters, Markus R Meyer, Hans H Maurer, 2010, Analytical and bioanalytical chemistry.

What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?

Hans H Maurer, H. Maurer, 2013, Journal of chromatography. A.

Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA.

Frank T Peters, Thomas Kraemer, Hans H Maurer, 2005, Clinical chemistry.

Forensic analysis on the cutting edge—New methods for trace evidence analysis Robert D. Blackledge, Editor

Hans H Maurer, 2008, Journal of the American Society for Mass Spectrometry.

Toward High-Throughput Drug Screening Using Mass Spectrometry

Frank T Peters, Hans H Maurer, F. Peters, 2005, Therapeutic drug monitoring.

Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for determination of amphetamine and methamphetamine enantiomers and its application to toxicology cases.

Frank T Peters, Thomas Kraemer, Hans H Maurer, 2002, Clinical chemistry.

Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types: A Synopsis

Roland F Staack, Dietmar Springer, Thomas Kraemer, 2004, Therapeutic drug monitoring.

The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).

Folker Westphal, Markus R Meyer, Golo M J Meyer, 2014, Drug testing and analysis.

Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today?

Markus R Meyer, Hans H Maurer, M. Meyer, 2016, Analytica chimica acta.

Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS.

Frank T Peters, Thomas Kraemer, Hans H Maurer, 2003, Journal of analytical toxicology.

Advances in analytical toxicology: the current role of liquid chromatography–mass spectrometry in drug quantification in blood and oral fluid

Hans H Maurer, H. Maurer, 2005, Analytical and bioanalytical chemistry.

Towards a universal LC-MS screening procedure - can an LIT LC-MS(n) screening approach and reference library be used on a quadrupole-LIT hybrid instrument?

Frank T Peters, Markus R Meyer, Armin A Weber, 2012, Journal of mass spectrometry : JMS.

Multiple stage MS in analysis of plasma, serum, urine and in vitro samples relevant to clinical and forensic toxicology.

Markus R Meyer, Hans H Maurer, M. Meyer, 2016, Bioanalysis.

Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry.

Frank T Peters, Hans H Maurer, F. Peters, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Metabolism of designer drugs of abuse.

Roland F Staack, Hans H Maurer, H. Maurer, 2005, Current drug metabolism.